Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Poisoning caused by carbamazepine (disorder) |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine blood measurement |
Component |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Serum carbamazepine measurement (procedure) |
Component |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Accidental poisoning by carbamazepine |
Causative agent (attribute) |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional poisoning by carbamazepine |
Causative agent (attribute) |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by carbamazepine of undetermined intent |
Causative agent (attribute) |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine adverse reaction (disorder) |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to carbamazepine |
Causative agent (attribute) |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Overdose of carbamazepine |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental overdose by carbamazepine |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional overdose by carbamazepine (disorder) |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de carbamazépine d'intention indéterminée |
Causative agent (attribute) |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxcarbazepine (substance) |
Is a |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine-10,11-epoxide measurement |
Component |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine measurement |
Component |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine-10,11-epoxide |
Is a |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carbamazepine 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 400mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carbamazepine 125 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 250 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 200 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 100 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing carbamazepine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 100mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 300mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 200mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 100mg/5 mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing carbamazepine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 100mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral form carbamazepine m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Plasma carbamazepine level (procedure) |
Component |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Carbamazepine 100mg/5mL oral liquid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carbamazepine 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental poisoning by carbamazepine |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional poisoning by carbamazepine |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of free carbamazepine (procedure) |
Component |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to carbamazepine |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 100mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 300mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 200mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 100mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine-10,11-epoxide |
Is modification of (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 125 milligram/1 each conventional release rectal suppository (clinical drug) |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 125 milligram/1 each conventional release rectal suppository (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 250 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 250 mg rectal suppository |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 100 mg chewable tablet |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 100 mg chewable tablet |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 200 mg chewable tablet |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 200 mg chewable tablet |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 100 mg oral tablet |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 100mg/5mL oral liquid (substance) |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine 100mg/5mL oral liquid (substance) |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only carbamazepine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fetal carbamazepine syndrome |
Causative agent (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 150 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 150 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 300 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carbamazepine 300 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbamazepine blood measurement |
Component |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum carbamazepine measurement (procedure) |
Component |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Plasma carbamazepine level (procedure) |
Component |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of free carbamazepine (procedure) |
Component |
True |
Carbamazepine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |